Back to XTX Topco Ltd XTX Topco Ltd

TGTXTGTX

Showing 8 of 16 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in TG Therapeutics, Inc.

No. XTX Topco exited its TGTX (TG Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 25,583 shares worth $849,867. XTX Topco first reported TGTX in Q2 2022 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$54.94
0
2026-Q1
New
25,583
—
$849,8670.0%$33.22
34
2025-Q4
Exited
0
-100.0%
$00.0%$29.81
0
2025-Q3
New
47,918
—
$1.7M0.1%$36.13
36
2025-Q2
Exited
0
-100.0%
$00.0%$35.99
0
2025-Q1
Increased
39,618
+197.8%
$1.6M0.1%$39.43
41
2024-Q4
New
13,304
—
$400,4500.0%$30.10
33
2024-Q3
Exited
0
-100.0%
$00.0%$23.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used